Skip to Content
Merck
All Photos(2)

Documents

B79803

Sigma-Aldrich

3-Bromopropylamine hydrobromide

98%

Synonym(s):

3-Aminopropyl bromide hydrobromide

Sign Into View Organizational & Contract Pricing


About This Item

Linear Formula:
BrCH2CH2CH2NH2 · HBr
CAS Number:
Molecular Weight:
218.92
Beilstein:
3906418
EC Number:
MDL number:
UNSPSC Code:
12352100
PubChem Substance ID:
NACRES:
NA.22

Assay

98%

form

crystals

mp

171-172 °C (lit.)

SMILES string

Br.NCCCBr

InChI

1S/C3H8BrN.BrH/c4-2-1-3-5;/h1-3,5H2;1H

InChI key

PQIYSSSTRHVOBW-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

Application

3-Bromopropylamine hydrobromide is commonly used as a reagent to introduce propylamine group to the molecular skeleton. Some of the other reported applications include:
  • Synthesis of photochemically and thermally reactive azobenzene rotaxane and indolocarbazole-containing [2]rotaxane.
  • Synthesis of indenoisoquinoline based active topoisomerase I inhibitors as anticancer agents.

Pictograms

Exclamation mark

Signal Word

Warning

Hazard Statements

Hazard Classifications

Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

Target Organs

Respiratory system

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Customers Also Viewed

Antagonist analogue of 6-[3 `-(1-adamantyl)-4 `-hydroxyphenyl]-2-naphthalenecarboxylic acid (AHPN) family of apoptosis inducers that effectively blocks AHPN-induced apoptosis but not cell-cycle arrest.
Dawson M I, et al.
Journal of Medicinal Chemistry, 47(14), 3518-3536 (2004)
Optimization of the indenone ring of indenoisoquinoline topoisomerase I inhibitors.
Morrell A, et al.
Journal of Medicinal Chemistry, 50(18), 4388-4404 (2007)
Maya Juenet et al.
Biomaterials, 156, 204-216 (2017-12-08)
Injection of recombinant tissue plasminogen activator (rt-PA) is the standard drug treatment for thrombolysis. However, rt-PA shows risk of hemorrhages and limited efficiency even at high doses. Polysaccharide-poly(isobutylcyanoacrylate) nanoparticles functionalized with fucoidan and loaded with rt-PA were designed to accumulate
Christina Gladkova et al.
Nature, 559(7714), 410-414 (2018-07-12)
Mutations in the E3 ubiquitin ligase parkin (PARK2, also known as PRKN) and the protein kinase PINK1 (also known as PARK6) are linked to autosomal-recessive juvenile parkinsonism (AR-JP)1,2; at the cellular level, these mutations cause defects in mitophagy, the process
Synthesis and anticancer activity of simplified indenoisoquinoline topoisomerase I inhibitors lacking substituents on the aromatic rings.
Nagarajan M, et al.
Journal of Medicinal Chemistry, 47(23), 5651-5661 (2004)

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service